Leggett & Platt (NYSE: LEG) director reports new stock awards

Rhea-AI Filing Summary

LEGGETT & PLATT director Joseph W. McClanathan reported two stock awards of Common Stock on April 15, 2026. He received 212.2301 shares at $9.08 per share in one grant and 46.8373 shares at the same price in another, both categorized as grant or award acquisitions rather than open-market purchases. Following these awards, his direct ownership increased to 119,825.8831 shares of Common Stock, reflecting routine equity-based compensation rather than a discretionary market trade.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider MCCLANATHAN JOSEPH W

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	212.23	$9.08	$2K
Grant/Award	Common Stock	46.837	$9.08	$425.28

Holdings After Transaction: Common Stock — 119,779.046 shares (Direct)

Footnotes (1)

Key Figures

First stock grant: 212.2301 shares Second stock grant: 46.8373 shares Award price per share: $9.08 per share +1 more

4 metrics

First stock grant 212.2301 shares Grant of LEG Common Stock on April 15, 2026

Second stock grant 46.8373 shares Additional grant of LEG Common Stock on April 15, 2026

Award price per share $9.08 per share Transaction price for both equity awards

Shares owned after awards 119,825.8831 shares Total direct LEG Common Stock holdings post-transaction

Key Terms

Common Stock, grant or award acquisition, non-derivative, Form 4

4 terms

Common Stock financial

"He received 212.2301 shares at $9.08 per share in one grant"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

grant or award acquisition financial

"both categorized as grant or award acquisitions rather than open-market purchases"

non-derivative financial

"These transactions were compensation-related grants, not open-market buys. They are coded as “A” for grant, award, or other acquisition and described as grant or award acquisitions"

Form 4 regulatory

"Director Joseph W. McClanathan reported receiving two small grants of LEG common stock as equity awards."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCCLANATHAN JOSEPH W

(Last) (First) (Middle)

NO 1 LEGGETT ROAD

(Street)

CARTHAGE MISSOURI 64836

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LEGGETT & PLATT INC [ LEG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/15/2026		A		212.2301	A	$9.08	119,779.0458	D
Common Stock	04/15/2026		A		46.8373	A	$9.08	119,825.8831	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Stanley Scott Luton, attorney-in-fact	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did LEG director Joseph McClanathan report in this Form 4 for LEG?

Director Joseph W. McClanathan reported receiving two small grants of LEG common stock as equity awards. These were classified as grant or award acquisitions, not open-market purchases, and modestly increased his direct ownership stake in the company’s shares.

How many LEG shares did Joseph McClanathan acquire through these awards?

He received 212.2301 LEG common shares in one grant and 46.8373 shares in another. Both transactions are reported as non-derivative grant or award acquisitions, reflecting routine equity compensation rather than market trading activity in the open market.

At what price were the LEG stock awards to Joseph McClanathan valued?

Both stock awards were valued at $9.08 per LEG share. This price is shown as the transaction price per share for each grant, providing a reference valuation for the equity compensation he received on the reported transaction date.

What is Joseph McClanathan’s LEG share ownership after these transactions?

After the reported equity awards, Joseph McClanathan directly owns 119,825.8831 LEG common shares. This figure reflects his post-transaction holdings, showing the updated size of his direct ownership position following the two grant or award acquisitions.

Were these LEG transactions open-market buys or compensation grants?

These transactions were compensation-related grants, not open-market buys. They are coded as “A” for grant, award, or other acquisition and described as grant or award acquisitions, indicating routine equity compensation awarded to the director rather than discretionary stock purchases.